Skip to main content

Advertisement

Table 1 Patient characteristics

From: Association between dexmedetomidine use for the treatment of alcohol withdrawal syndrome and intensive care unit length of stay

  Dexmedetomidine plus benzodiazepine, n = 141 Benzodiazepine alone, n = 297 p value
Female, N (%) 23 (16.3) 75 (25.2) 0.04
Age, mean (SD) 50.7 (11.3) 51.6 (12.5) 0.4
BMI, mean (SD) 25.4 (5.4) 25.9 (5.6) 0.4
Pre-ICU admission seizure, N (%) 12 (8.5) 33 (11.1) 0.4
Admission CIWA, mean (SD) 20.4 (10.2) 15.5 (8.7) < 0.0001
Alcohol withdrawal severity, N (%) < 0.0001
 Mild (admission CIWA 1–10) 21 (14.9) 91 (30.6)
 Moderate (admission CIWA 11–20) 54 (38.3) 128 (43.1)
 Severe admission CIWA (> 20) 66 (46.8) 78 (26.3)
APACHE IVa. mean (SD) 40.2 (13.0) 39.7 (15.2) 0.7
APACHE IVa within CIWA groups
 Mild (1–10) 39.5 (10.4) 38.9 (14.2) 0.5
 Moderate (11–20) 38.5 (12.0) 40.3 (16.5)
 Severe (> 20) 41.8 (14.6) 39.6 (14.4)
Pre-ICU LOS (h), mean (SD) 23.4 (32.4) 9.3 (18.3) < 0.0001
ICU Discharge CIWA, mean (SD) 6.6 (4.7) 6.4 (5.2) 0.6
ICU LOS (h), mean (SD) 88.7 (74.0) 37.3 (36.2) < 0.0001
Duration of dexmedetomidine treatment (h), mean (SD) 60.9 (53.7)  
 Mild CIWA (1–10) 47.9 (41.1)
 Moderate CIWA (11–20) 80.5 (60.1)
 Severe CIWA (> 20) 48.9 (46.3)